Analysts Offer Insights on Healthcare Companies: Springworks Therapeutics (SWTX), Cyclo Therapeutics (CYTH) and Oncternal Therapeutics (ONCT)
Oncternal Therapeutics Analyst Ratings
Oppenheimer Remains a Hold on Oncternal Therapeutics (ONCT)
Oncternal Therapeutics Analyst Ratings
Oppenheimer Reaffirms Their Hold Rating on Oncternal Therapeutics (ONCT)
Oncternal Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Joint (JYNT), Xtant Medical Holdings (XTNT) and Oncternal Therapeutics (ONCT)
Oppenheimer Remains a Hold on Oncternal Therapeutics (ONCT)
Oncternal Therapeutics Analyst Ratings
Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Oncternal Therapeutics (ONCT)
Oncternal Therapeutics Analyst Ratings
Brookline Capital Upgrades Oncternal Therapeutics to Buy, Announces $2 Price Target
Oncternal Therapeutics Analyst Ratings
Buy Rating for Oncternal Therapeutics: Promising Clinical Programs and Potential Catalysts
Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Oncternal Therapeutics (ONCT) and Ventyx Biosciences (VTYX)
HC Wainwright & Co. Upgrades Oncternal Therapeutics to Buy, Announces $2 Price Target
Oncternal Therapeutics Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on Oncternal Therapeutics, Maintains $1.3 Price Target
Oncternal Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Oncternal Therapeutics (ONCT), Adagene (ADAG) and Omega Therapeutics (OMGA)